Literature DB >> 22559663

Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: report of the AAPM and ESTRO.

Jose Perez-Calatayud1, Facundo Ballester, Rupak K Das, Larry A Dewerd, Geoffrey S Ibbott, Ali S Meigooni, Zoubir Ouhib, Mark J Rivard, Ron S Sloboda, Jeffrey F Williamson.   

Abstract

PURPOSE: Recommendations of the American Association of Physicists in Medicine (AAPM) and the European Society for Radiotherapy and Oncology (ESTRO) on dose calculations for high-energy (average energy higher than 50 keV) photon-emitting brachytherapy sources are presented, including the physical characteristics of specific (192)Ir, (137)Cs, and (60)Co source models.
METHODS: This report has been prepared by the High Energy Brachytherapy Source Dosimetry (HEBD) Working Group. This report includes considerations in the application of the TG-43U1 formalism to high-energy photon-emitting sources with particular attention to phantom size effects, interpolation accuracy dependence on dose calculation grid size, and dosimetry parameter dependence on source active length.
RESULTS: Consensus datasets for commercially available high-energy photon sources are provided, along with recommended methods for evaluating these datasets. Recommendations on dosimetry characterization methods, mainly using experimental procedures and Monte Carlo, are established and discussed. Also included are methodological recommendations on detector choice, detector energy response characterization and phantom materials, and measurement specification methodology. Uncertainty analyses are discussed and recommendations for high-energy sources without consensus datasets are given.
CONCLUSIONS: Recommended consensus datasets for high-energy sources have been derived for sources that were commercially available as of January 2010. Data are presented according to the AAPM TG-43U1 formalism, with modified interpolation and extrapolation techniques of the AAPM TG-43U1S1 report for the 2D anisotropy function and radial dose function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22559663     DOI: 10.1118/1.3703892

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  52 in total

1.  Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.

Authors:  Blake Currier; John J Munro; David C Medich
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

2.  Surface dose characterisation of the Varian Ir-192 HDR conical surface applicator set with a vertically orientated source.

Authors:  Konrad Buchauer; Guido Henke; Hans Schiefer; Ludwig Plasswilm
Journal:  Strahlenther Onkol       Date:  2014-08-01       Impact factor: 3.621

3.  Current state of the art brachytherapy treatment planning dosimetry algorithms.

Authors:  P Papagiannis; E Pantelis; P Karaiskos
Journal:  Br J Radiol       Date:  2014-07-16       Impact factor: 3.039

Review 4.  Air kerma and absorbed dose standards for reference dosimetry in brachytherapy.

Authors:  T Sander
Journal:  Br J Radiol       Date:  2014-07-07       Impact factor: 3.039

5.  Dose distribution verification for GYN brachytherapy using EBT Gafchromic film and TG-43 calculation.

Authors:  Somayeh Gholami; Hamid Reza Mirzaei; Ali Jabbary Arfaee; Ramin Jaberi; Hassan Ali Nedaie; Seied Rabi Mahdavi; Eftekhar Rajab Bolookat; Ali S Meigooni
Journal:  Rep Pract Oncol Radiother       Date:  2016-07-18

6.  Evaluation of hypothetical (153)Gd source for use in brachytherapy.

Authors:  Mahdi Ghorbani; Marziyeh Behmadi
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-27

Review 7.  A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for HDR brachytherapy.

Authors:  Yousif A M Yousif; Alexander F I Osman; Mohammed A Halato
Journal:  Phys Eng Sci Med       Date:  2021-06-17

8.  Assessment of dose uniformity around high dose rate 192Ir and 60Co stepping sources.

Authors:  Bagher Farhood; Mahdi Ghorbani
Journal:  Radiol Phys Technol       Date:  2017-09-18

9.  A directional 103Pd brachytherapy device: Dosimetric characterization and practical aspects for clinical use.

Authors:  Mark J Rivard
Journal:  Brachytherapy       Date:  2016-12-28       Impact factor: 2.362

10.  Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.

Authors:  Hualin Zhang; Eric D Donnelly; Jonathan B Strauss; Yujin Qi
Journal:  Med Phys       Date:  2016-01       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.